Insider Transactions in Q1 2023 at Uro Gen Pharma Ltd. (URGN)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 31
2023
|
Elizabeth A. Barrett Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,333
+2.75%
|
-
|
|
Jan 31
2023
|
Mark Schoenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,900
-0.43%
|
$19,000
$10.12 P/Share
|
|
Jan 31
2023
|
Mark Schoenberg Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,833
+0.85%
|
-
|
|
Jan 31
2023
|
Jason Drew Smith General Counsel |
SELL
Open market or private sale
|
Direct |
1,636
-5.63%
|
$16,360
$10.12 P/Share
|
|
Jan 31
2023
|
Jason Drew Smith General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,333
+10.11%
|
-
|
|
Jan 20
2023
|
Mark Schoenberg Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
122,677
+45.55%
|
$613,385
$5.0 P/Share
|